#Laser Benign Prostatic Hyperplasia (BPH) Devices Market Share | Explore Tumblr posts and blogs

databridgemarketresearchreports · 20 days ago

Text

Laser Benign Prostatic Hyperplasia (BPH) Devices Market Insights | Growth, Trends and Advancements | 2025 - 2032

The Latest Trending Laser Benign Prostatic Hyperplasia (BPH) Devices Market sector is on the brink of remarkable evolution, with projections indicating robust growth and groundbreaking technological advancements by 2032. A recent comprehensive market research report highlights the sector's promising trajectory, fueled by key drivers including expanding market size, increasing market share, and the emergence of innovative trends.

This comprehensive report provides key insights into the Laser Benign Prostatic Hyperplasia (BPH) Devices market, exploring critical market segmentation and definitions. It highlights the essential components driving growth, offering a clear picture of the industry's trajectory. Utilizing SWOT and PESTEL analyses, the report evaluates the market's strengths, weaknesses, opportunities, and threats, while also considering political, economic, social, technological, environmental, and legal factors that impact the market landscape.

The study offers valuable insights into the competitive landscape, highlighting recent developments and geographical distribution across key regions. Expert competitor analysis provides a detailed understanding of market dynamics, offering strategic guidance for businesses and investors.

With robust analysis and future projections, this report serves as a vital resource for stakeholders looking to capitalize on emerging opportunities and navigate challenges in the Laser Benign Prostatic Hyperplasia (BPH) Devices market.

What is the projected market size & growth rate of the Laser Benign Prostatic Hyperplasia (BPH) Devices Market?

Market Analysis and Size

Benign prostatic hyperplasia (BPH) refers to a condition where the prostate gets enlarged or it could be defined as a noncancerous increase in the size of the prostate gland. Various several different types of prostate laser surgery, such as Holmium laser ablation of the prostate (HoLAP), Holmium laser enucleation of the prostate (HoLEP) and Photoselective vaporization of the prostate (PVP).

Symptoms may include trouble starting to urinate, inability to urinate, frequent urination and weak stream. Global laser benign prostatic hyperplasia (BPH) devices market was valued at USD 456.62 million in 2021 and is expected to reach USD 781.61 million by 2029, registering a CAGR of 6.60% during the forecast period of 2022-2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Browse Detailed TOC, Tables and Figures with Charts which is spread across 350 Pages that provides exclusive data, information, vital statistics, trends, and competitive landscape details in this niche sector.

This research report is the result of an extensive primary and secondary research effort into the Laser Benign Prostatic Hyperplasia (BPH) Devices market. It provides a thorough overview of the market's current and future objectives, along with a competitive analysis of the industry, broken down by application, type and regional trends. It also provides a dashboard overview of the past and present performance of leading companies. A variety of methodologies and analyses are used in the research to ensure accurate and comprehensive information about the Laser Benign Prostatic Hyperplasia (BPH) Devices Market.

Get a Sample PDF of Report - https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-laser-bph-devices-market

Which are the driving factors of the Laser Benign Prostatic Hyperplasia (BPH) Devices market?

The driving factors of the Laser Benign Prostatic Hyperplasia (BPH) Devices market include technological advancements that enhance product efficiency and user experience, increasing consumer demand driven by changing lifestyle preferences, and favorable government regulations and policies that support market growth. Additionally, rising investment in research and development and the expanding application scope of Laser Benign Prostatic Hyperplasia (BPH) Devices across various industries further propel market expansion.

Laser Benign Prostatic Hyperplasia (BPH) Devices Market - Competitive and Segmentation Analysis:

Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market, By Product (Argon, Carbon Dioxide YAG Laser, Diode Laser, Others), Medium Base (Gas, Liquid, Solid), Modality (Table Top, Fixed, Trolley Mounted),Application (Holmium Laser Enucleation Of The Prostate (HOLEP), Holmium Laser Ablation Of The Prostate (HOLAP), Photoselective Vaporization Of The Prostate (PVP)), End User (Ambulatory Surgical Centres (ASC), Urology Centre, Hospitals, Speciality Clinics, Others) – Industry Trends and Forecast to 2032.

How do you determine the list of the key players included in the report?

With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.

Which are the top companies operating in the Laser Benign Prostatic Hyperplasia (BPH) Devices market?

Some of the major players operating in the laser benign prostatic hyperplasia (BPH) devices market are Endo Pharmaceuticals Inc. (Ireland), KARL STORZ SE & Co. KG (Germany), Lumenis. (Israel), Olympus Winter & IBE GMBH (Germany), Urologix, LLC. (US), Boston Scientific Corporation (US), LISA Laser USA (US), ProArc Medical (Israel), Urovision-Urotech (Germany), Teleflex Incorporated. (US), Richard Wolf GmbH. (Germany), BD (US), biolitec AG (Germany), Coloplast Corp (Denmark), among other.

Short Description About Laser Benign Prostatic Hyperplasia (BPH) Devices Market:

The Global Laser Benign Prostatic Hyperplasia (BPH) Devices market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

North America, especially The United States, will still play an important role which can not be ignored. Any changes from United States might affect the development trend of Laser Benign Prostatic Hyperplasia (BPH) Devices. The market in North America is expected to grow considerably during the forecast period. The high adoption of advanced technology and the presence of large players in this region are likely to create ample growth opportunities for the market.

Europe also play important roles in global market, with a magnificent growth in CAGR During the Forecast period 2025-2032.

Laser Benign Prostatic Hyperplasia (BPH) Devices Market size is projected to reach Multimillion USD by 2032, In comparison to 2025, at unexpected CAGR during 2025-2032.

Despite the presence of intense competition, due to the global recovery trend is clear, investors are still optimistic about this area, and it will still be more new investments entering the field in the future.

This report focuses on the Laser Benign Prostatic Hyperplasia (BPH) Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Get a Sample Copy of the Laser Benign Prostatic Hyperplasia (BPH) Devices Report 2025

What are your main data sources?

Both Primary and Secondary data sources are being used while compiling the report. Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users. Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2025-2032) of the following regions are covered in Chapters

What are the key regions in the global Laser Benign Prostatic Hyperplasia (BPH) Devices market?

North America (United States, Canada and Mexico)

Europe (Germany, UK, France, Italy, Russia and Turkey etc.)

Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)

South America (Brazil, Argentina, Columbia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

This Laser Benign Prostatic Hyperplasia (BPH) Devices Market Research/Analysis Report Contains Answers to your following Questions

What are the global trends in the Laser Benign Prostatic Hyperplasia (BPH) Devices market?

Would the market witness an increase or decline in the demand in the coming years?

What is the estimated demand for different types of products in Laser Benign Prostatic Hyperplasia (BPH) Devices?

What are the upcoming industry applications and trends for Laser Benign Prostatic Hyperplasia (BPH) Devices market?

What Are Projections of Global Laser Benign Prostatic Hyperplasia (BPH) Devices Industry Considering Capacity, Production and Production Value? What Will Be the Estimation of Cost and Profit? What Will Be Market Share, Supply and Consumption? What about Import and Export?

Where will the strategic developments take the industry in the mid to long-term?

What are the factors contributing to the final price of Laser Benign Prostatic Hyperplasia (BPH) Devices?

What are the raw materials used for Laser Benign Prostatic Hyperplasia (BPH) Devices manufacturing?

How big is the opportunity for the Laser Benign Prostatic Hyperplasia (BPH) Devices market?

How will the increasing adoption of Laser Benign Prostatic Hyperplasia (BPH) Devices for mining impact the growth rate of the overall market?

How much is the global Laser Benign Prostatic Hyperplasia (BPH) Devices market worth? What was the value of the market In 2024?

Who are the major players operating in the Laser Benign Prostatic Hyperplasia (BPH) Devices market? Which companies are the front runners?

Which are the recent industry trends that can be implemented to generate additional revenue streams?

What Should Be Entry Strategies, Countermeasures to Economic Impact, and Marketing Channels for Laser Benign Prostatic Hyperplasia (BPH) Devices Industry?

Customization of the Report

Can I modify the scope of the report and customize it to suit my requirements? Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.

Inquire more and share questions if any before the purchase on this report at - https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-laser-bph-devices-market

Detailed TOC of Global Laser Benign Prostatic Hyperplasia (BPH) Devices Market Insights and Forecast to 2032

Introduction

Market Segmentation

Executive Summary

Premium Insights

Market Overview

Laser Benign Prostatic Hyperplasia (BPH) Devices Market By Type

Laser Benign Prostatic Hyperplasia (BPH) Devices Market By Function

Laser Benign Prostatic Hyperplasia (BPH) Devices Market By Material

Laser Benign Prostatic Hyperplasia (BPH) Devices Market By End User

Laser Benign Prostatic Hyperplasia (BPH) Devices Market By Region

Laser Benign Prostatic Hyperplasia (BPH) Devices Market: Company Landscape

SWOT Analysis

Company Profiles

Continued...

Purchase this report – https://www.databridgemarketresearch.com/checkout/buy/singleuser/global-laser-bph-devices-market

Data Bridge Market Research:

Today's trends are a great way to predict future events!

Data Bridge Market Research is a market research and consulting company that stands out for its innovative and distinctive approach, as well as its unmatched resilience and integrated methods. We are dedicated to identifying the best market opportunities, and providing insightful information that will help your business thrive in the marketplace. Data Bridge offers tailored solutions to complex business challenges. This facilitates a smooth decision-making process. Data Bridge was founded in Pune in 2015. It is the product of deep wisdom and experience.

Data Bridge Market Research

US: +1 614 591 3140

UK: +44 845 154 9652

APAC: +653 1251 975

Email:- [email protected]

Browse More Reports:

Electric Motor Sales Market

Cold Plasma Market

Hair Wigs and Extension Market

Laser Benign Prostatic Hyperplasia (BPH) Devices Market

Wi-Fi as a Service Market

0 notes

bhavnadbmr · 2 months ago

Text

0 notes

chemicalsmaterial · 3 years ago

Text

Middle East and Africa Benign Prostatic Hyperplasia Devices Market Growth and Analysis

Middle East and Africa Benign Prostatic Hyperplasia Devices Market will exhibit a growth rate of 11% for the forecast period of 2021-2028

Middle East and Africa Benign Prostatic Hyperplasia Devices Market Analysis and Insights:

Benign prostatic hyperplasia (BPH) is defined as a non-cancerous enlargement of prostate gland. Benign prostatic hypertrophy is also called benign prostatic obstruction or benign prostatic hypertrophy. It is a condition that mostly occurs in men. The prostate gland typically goes through two major growth stages as man ages. The first phase occurs at the onset of puberty, when the prostate gland doubles in size, while the second phase of growth occurs around age 25 and continues for most of a man's life. BPH usually develop with the second stage of growth.

The rise in the prevalence of benign prostatic hyperplasia amongst men along with increasing risk factors will cushion the demand for advanced medical devices and act as major drivers influencing the growth of benign prostatic hyperplasia devices market. Furthermore, surge in the demand for minimally invasive treatment, rise in the number geriatric population and developments associated with innovate and advanced BPH treatment devices are the factors that will enhance the growth of benign prostatic hyperplasia devices market. Also, growing popularity of robotic assistance surgical techniques and presence of favourable reimbursement facilities will accelerate the market growth rate.

Moreover, rising healthcare sector in emerging economies and technological advancement related with benign prostatic hyperplasia devices will create beneficial opportunities for the market growth.

However, high cost associated with benign prostatic hyperplasia devices and side effects related with the BPH medications act as market restraints that will obstruct the market growth. Less awareness about prostate health among men and product recalls will further challenge the benign prostatic hyperplasia devices market.

Middle East and Africa benign prostatic hyperplasia devices market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Middle East and Africa benign prostatic hyperplasia devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Middle East and Africa Benign Prostatic Hyperplasia Devices Market Scope and Market Size:

On the basis of procedure type, the benign prostatic hyperplasia devices market is segmented into transurethral resection of the prostate (TURP), prostatic urethral lift (PUL), prostatectomy, laser surgery, transurethral microwave therapy (TUMT), transurethral needle ablation of the prostate (TUNA), prostatic stenting/implants and others.

On the basis of end user, the benign prostatic hyperplasia devices market is bifurcated into hospitals and clinics, ambulatory surgical centers and others.

Get full report here: https://www.databridgemarketresearch.com/reports/middle-east-africa-benign-prostatic-hyperplasia-devices-market

Middle East and Africa Benign Prostatic Hyperplasia Devices Market Country Level Analysis:

The countries covered in the Middle East and Africa Benign Prostatic Hyperplasia Devices market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..

Get Sample Report here: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=middle-east-africa-benign-prostatic-hyperplasia-devices-market

Major TOC of the Report:

Chapter One: Introduction

Chapter Two: Market Segmentation

Chapter Three: Market Overview

Chapter Four: Executive Summary

Chapter Five: Premium Insight

Chapter Six: COVID-19 Impact on Middle East and Africa Benign Prostatic Hyperplasia Devices Market

Get TOC here: https://www.databridgemarketresearch.com/toc/?dbmr=middle-east-africa-benign-prostatic-hyperplasia-devices-market

Competitive Landscape and Sutures Market Share Analysis:

The Middle East and Africa Benign Prostatic Hyperplasia Devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to Middle East and Africa Benign Prostatic Hyperplasia Devices market.

Major Players:

KARL STORZ,

OmniGuide Holdings, Inc.,

Olympus Corporation,

Richard Wolf GmbH,

Lumenis,

Urologix, LLC,

Boston Scientific Corporation,

Coloplast Corp,

Medifocus Inc.

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: [email protected]

#Middle East and Africa Benign Prostatic Hyperplasia Devices Market Growth

0 notes

researchupdates · 3 years ago

Text

Global Benign Prostatic Hyperplasia Devices Market Growth Statistics to Make Multi-Billion Dollar Market during 2021-2028

Global Benign Prostatic Hyperplasia Devices Market Overview:

Each section of the superior Benign Prostatic Hyperplasia Devices business research report is specially prepared to investigate key aspects of the Market. This Market document also entails a detailed analysis of the current applications and comparative analysis with a keen focus on the opportunities and threats and competitive analysis of major companies. It is helpful in knowing the general conditions prevailing in the Market, the Marketing and pricing strategy of competitors. The Market has exhibited continuous growth in recent years and is projected to grow even further during the forecast period (2021-2026). The world class Benign Prostatic Hyperplasia Devices Market report is a window to the industry which talks about what Market definition, classifications, applications, engagements and Market trends are.

Benign Prostatic Hyperplasia Devices Market analysis report documents a detailed analysis of the Market, compiling current growth factors, future trends, attentive opinions, historical data, facts, and statistically supported and industry-validated Market data. The industry report gives CAGR value fluctuation during the forecast period of 2021-2026 for the Market. This Market study also evaluates the Market status, Market share, growth rate, future trends, Market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis. Benign Prostatic Hyperplasia Devices is a professional and a detailed report focusing on primary and secondary drivers, Market share, leading segments and geographical analysis.

Available Exclusive Sample Copy of this Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-benign-prostatic-hyperplasia-devices-market .

The Global Benign Prostatic Hyperplasia Devices Market is expected to reach at a CAGR of 12.2% in the forecast period of 2019 to 2026.

According to the market report analysis, Benign Prostatic Hyperplasia is also called as BPH which is a condition in men where the prostate gland is enlarged and is not cancerous. Benign prostatic hyperplasia is also known as benign prostatic obstruction or benign prostatic hypertrophy. The prostate usually goes through 2 main growth stages as a man ages.

Top Leading Key in Players Global Benign Prostatic Hyperplasia Devices Market: KARL STORZ SE & Co. KG, Olympus Corporation, Richard Wolf GmbH, Lumenis, Urologix, LLC, Boston Scientific Corporation, Coloplast Corp, LISA Laser Products GmbH, Medifocus, Inc., Coloplast Corp, Teleflex Incorporated, Urotech Devices, BD, PROCEPT BioRobotics Corporation, Biolitec AG and others. New product launches and continuous technological innovations are the key strategies adopted by the major players.

Access Complete Report @ https://www.databridgemarketresearch.com/reports/global-benign-prostatic-hyperplasia-devices-market .

#Benign Prostatic Hyperplasia Devices #BD #KARL STORZ #Olympus #Richard Wolf #Lumenis

0 notes

healtcare · 4 years ago

Text

Global Benign Prostatic Hyperplasia Treatment Market

Global Benign Prostatic Hyperplasia Treatment Market is expected to reach US$ XX Mn by 2026 from US$ XX Mn in 2019, at a CAGR of 5.2% during the forecast period.

Global Benign Prostatic Hyperplasia Treatment Market Overview:

Benign Prostatic Hyperplasia (BHP) is a medical condition, in which the prostate gland gets enlarged and commonly diagnosed in males. It is basically the non-cancerous growth of the gland developed from the prostate cell. The most common indications of these conditions are difficulties in initiating urine, frequent urination, and a weak urinary system.

Global Benign Prostatic Hyperplasia Treatment Market Dynamics:

Adaptation of unhealthy lifestyle is the key driver contributing to the market growth. Other factors like the growing population of elderly men and family history encourage the market growth. About one-third of men experience moderate to severe symptoms by age 60, and about half do so by age 80 and heredity causes an increase in the risk of contracting BPH. As many as 14 million men in the United States have symptoms of BPH. Worldwide, approximately 30 million men have symptoms related to BPH. Studies show that diabetes, as well as heart disease and the use of beta-blockers, might increase the risk of BPH, which in turn raises demand for the BPH treatment market. In addition, the growing health awareness and early diagnosis of the medical condition fuelling the demand for the treatment and propel the market growth. Along with this, the rising preference for minimally invasive surgeries, increasing obesity rate, and investments, funds, and grants for research in the field of BPH treatment stimulate the growth of the BPH treatment market. However, the high price involving the benign prostatic hyperplasia treatment, expected to hamper the market growth. In addition to this, side effects associated with the BPH medications like dizziness, orthostatic hypotension, retrograde ejaculation, and rhinitis and apart from these some drugs also reduce the synthesis of several neuro-active steroids may impact negatively on the market growth. The patent expiration of many products has paved the way for a new promising product pipeline high potential in untapped markets of the emerging economies is anticipated to provide lucrative growth opportunities for the market growth during the forecast years. The report has profiled twenty-nine key players in the market from different regions. However, the report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for a future hot spot in APAC region.

Global Benign Prostatic Hyperplasia Treatment Market Segment Analysis:

The global Benign Prostatic Hyperplasia Treatment market is segmented on the basis of Drug Type, Surgery Type and End-Users. Based on Drug Type, the alpha-blockers segment is expected to hold a prominent market share over the forecast years. Alpha-blockers help in relaxing the muscle of the prostate and the bladder neck, which allow urine to flow easier. Alpha-blockers — which include alfuzosin (Uroxatral), doxazosin (Cardura), tamsulosin (Flomax) and silodosin (Rapaflo) — usually work quickly in men with relatively small prostates. In Japan, α1 blockers are recommended in the clinical guidelines for BPH as first-line drug therapy for lower urinary tract symptoms (LUTS) associated with BPH. Nymox Pharmaceutical Corporation has developed NX-1207 (fexapotide triflutate), a novel compound that is administered transrectally. In July 2015, Nymox announced that its Phase III clinical study of NX-1207 had successfully met its primary endpoints. This injection lasts for a mean duration of 3.5 years after a single injection. The NX-1207 is considered to be safe as compared to existing treatments with minimal side effects. Based on Surgery Type, the TURP (Transurethral resection of the prostate) segment is considered to be dominant over the forecast years. TURP is an endoscopic electrosurgical procedure involving the removal of a portion of the prostate to relieve voiding obstruction associated with BPH. A lighted scope is inserted into your urethra, and the surgeon removes all but the outer part of the prostate. Owing to the growing trend, nowadays, TURP is being performed on an outpatient basis and selected patients are granted discharge within 24 hours of admission. Advantages associated with TURP such as less hospital stay and quick recovery encourage the segment to grow at a faster pace during the forecast period. To know about the Research Methodology :- Request Free Sample Report

Global Benign Prostatic Hyperplasia Treatment Market Regional Insights:

North America region is anticipated to hold the largest market share. The high prevalence of BPH and other associated lower urinary tract symptoms present in the region is the major factor dominating the market in North America. Several studies in the past era have reported a significant percentage of men in the US, aged between 45 and 80 years suffer from some type of lower urinary tract symptoms and most have some form of BPH symptoms. Collaboration of many hospitals with non-profit organization and companies in the US and Canada, contribute to raising awareness and adequate resources for the treatment of urological disorders. The American Medical Systems portfolio acquisition included the procurement of leading products for the treatment of a variety of urologic conditions, including the minimally invasive GreenLight XPS laser therapy system. Asia-Pacific region is anticipated to grow at a faster pace during the forecast period, owing to a high population base, increase in disposable income, and enhanced patient awareness about the benign prostatic hyperplasia condition. The report also helps in understanding the Global Benign Prostatic Hyperplasia Treatment Market dynamics, structure by analyzing the market segments and project the Global Benign Prostatic Hyperplasia Treatment Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Benign Prostatic Hyperplasia Treatment Market make the report investor’s guide.

Global Benign Prostatic Hyperplasia Treatment Market Key Developments:

• In August 2015, Boston Scientific completed its acquisition of American Medical Systems’ Male Urology Portfolio from Endo Pharmaceuticals for $1.6bn, with the potential for an additional $50m in milestone payments predicated on 2016 sales. As a result of this acquisition, Boston Scientific positioned itself as the market leader in laser-based surgery systems and an overall leader in urology with its comprehensive portfolio. The new business portfolio was combined with Boston Scientific’s Urology and Women’s Health businesses to create the new Urology and Pelvic Health business. • The new handheld Rezūm device manufactured by NxThera, performs Prostate Convective WAVE ablation. This innovation is considered as a source of growth in the market for office-based thermotherapy for symptomatic BPH. The Rezūm device is expected to see an increase in sales over the forecast period.

Global Benign Prostatic Hyperplasia Treatment Market Scope: Inquire before buying

Global Benign Prostatic Hyperplasia Treatment Market, by Region

• North America • Europe • South America • MEA • APAC

Global Benign Prostatic Hyperplasia Treatment Market Key Players

• Boston Scientific Corporation • Coloplast Group • Teleflex Incorporated • Olympus Corporation • GlaxoSmithKline PLC • Eli Lilly • Pfizer, Inc. • Abbott • Asahi Kasei Corporation • Merck & Co., Inc. • Astellas Pharma Inc. • Allergan plc • Alembic • IPG Photonics Corporation • Richard Wolf GmbH • Unilab, Inc. • Pharex Health Corporation • Biolitec AG • Urologix, LLC • Advin Health Care • Medifocus, Inc. • Asclepion Laser Technologies GmbH • Pnn Medical A/S • Surgical Lasers Inc. • Quanta Systems • Allium Ltd. • Lumenis Ltd. • KARL STORZ SE & Co. KG • SRS Medical

#Benign Prostatic Hyperplasia #Benign Prostatic Hyperplasia Treatment

0 notes

linhgd9 · 4 years ago

Text

Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market 2020 Analysis by Key Players, Progression Status and Business Trends to 2025

This research report titled Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 released by MarketQuest.biz scrutinizes market size, market share, status, trends, competitive scenario, and potential growth opportunities with forecast till 2025. The report helps in getting answers to the relevant questions with respect to the developing trends and growth opportunities in this industry. The report contains important data accumulated from pertinent sources. The study profiles and examines leading companies and other prominent companies operating in the industry. The restraints are also given, which proves to be a prospect for this market during the forecast period of 2020 to 2025 respectively. The strong trends that shape the growth pattern of the global market are scrutinized in the report in detail.

Market Segmentation Analysis:

The report studies the diverse product segments and end-user applications segment of the global Benign Prostatic Hyperplasia (BPH) Treatment Devices market, as well as evaluates the growth of individual segments of the market. In addition, the market size and the growth rate of each of the segments have been evaluated in the report. The trends within various application segments of the global market are recognized and barriers to growth are identified in the report. Also, the report considers the key geographic segments and talks about all the favorable conditions boosting the growth of the global Benign Prostatic Hyperplasia (BPH) Treatment Devices market. The report focuses on opportunities of the market and restraining factors of the market.

NOTE: Our report highlights the major issues and hazards that companies might come across due to the unprecedented outbreak of COVID-19.

DOWNLOAD FREE SAMPLE REPORT: https://www.marketquest.biz/sample-request/22939

Objectives of This Research Report:

To provide a comprehensive view of the global Benign Prostatic Hyperplasia (BPH) Treatment Devices market

To offer a complete analysis of changing competitive scenario

To make up to date business decisions in the businesses

To Identify the global clients and understand their requirements

To discover the potential growth opportunities

To analyze the target market across the globe

To offers a detailed analysis of global Benign Prostatic Hyperplasia (BPH) Treatment Devices market segments

The prominent players of the market are: Advin Urology, JenaSurgical GmbH, CONMED, Biolitec, HistoSonics, Inc., Boston Scientific Corporation, LISA Laser Products GmbH, CoreTherm Medical, Inc. (ProstaLund), Convergent Laser Technologies, KARL STORZ, Siemens, NeoTract, Lumenis Ltd., Baxter International, Olympus, Medtronic, Medifocus, Inc., Urotech, Urologix, Endo International

The study is segmented by the following product type: Surgical Treatment, Minimally Invasive Treatment, Laser Treatment, Other

Major applications/end-users industry are as follows: , Fertility Clinics, Hospitals, Others

Following the fundaments, the market is segmented on the basis of geography: North America (United States, Canada and Mexico), Europe (Germany, France, United Kingdom, Russia and Italy), Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia), South America (Brazil, Argentina), Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa)

ACCESS FULL REPORT: https://www.marketquest.biz/report/22939/global-benign-prostatic-hyperplasia-bph-treatment-devices-market-2020-by-manufacturers-regions-type-and-application-forecast-to-2025

The report covers the analysis of the specific product application contribution to the market in terms of volume, size, and revenue. Furthermore, it uncloses potential future market applications that can impact the growth of the global Benign Prostatic Hyperplasia (BPH) Treatment Devices market. An in-depth assessment of the regional market analysis which includes growth factors, performance, and potential sales in the forecast period has been provided. The research study goes through the proper research methodology, validated by the professionals and analysts.

Customization of the Report:

This report can be customized to meet the client’s requirements. Please connect with our sales team ([email protected]), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

Contact Us Mark Stone Head of Business Development Phone: +1-201-465-4211 Email: [email protected] Web: www.marketquest.biz

from NeighborWebSJ https://ift.tt/3wp3Yqu via IFTTT

from WordPress https://ift.tt/31AHrZC via IFTTT

#WordPress

0 notes

sandlerresearch · 4 years ago

Text

Benign Prostatic Hyperplasia Treatment Market by Type [Drug (Alpha Blockers(Tamsulosin, Doxazosin), 5-Alpha Reductase Inhibitors (Finasteride, Dutasteride), Surgical Treatment (TURP, TUMT, TUNA], End User (Hospitals) - Global Forecast to 2026 published on

https://www.sandlerresearch.org/benign-prostatic-hyperplasia-treatment-market-by-type-drug-alpha-blockerstamsulosin-doxazosin-5-alpha-reductase-inhibitors-finasteride-dutasteride-surgical-treatment-turp-tumt-tuna-end.html

“Benign prostatic hyperplasia treatment market is projected to grow at CAGR of 5.3% from 2021 to 2026”

The global benign prostatic hyperplasia treatment market is projected to reach USD 14.1 billion by 2026 from USD 10.8 billion in 2021, at a CAGR of 5.3% from 2021 to 2026. The growth of this market is driven owing to the increasing prevalence of benign prostatic hyperplasia, the rising preference for minimally invasive surgeries, increasing obesity rate, and investments, funds, and grants for research in the field of BPH treatment. Also, the emerging markets and promising product pipeline is anticipated to offer an opportunity for the growth of the market during the forecast period.

“Drug treatment is expected to hold the largest share of the benign prostatic hyperplasia treatment market, by type in 2021.”

Based on the type, the BPH treatment market is segmented into drug treatment and surgical treatment. Drug treatment is the largest and the fastest-growing segment in this market. This can primarily be attributed to the use of medications as the first line of treatment among men with mild to moderate symptoms of BPH.

“Home healthcare is expected to hold the largest share of the benign prostatic hyperplasia treatment market, in 2021.”

Based on the end user, the market is segmented into home healthcare and hospitals & clinics. In 2019, home healthcare accounted for the largest share of this market, as most patients are prescribed medications over surgery. Patients are also advised to continue taking medications for a few weeks post-surgery and may even require catheters for a few days. As a result, the emphasis in his market is skewed toward home healthcare over hospital care.

“North America commanded the largest share of the benign prostatic hyperplasia treatment market in 2021.”

On the basis of region, the benign prostatic hyperplasia treatment market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2019, North America commanded the largest share of the benign prostatic hyperplasia treatment market. The large share of this market segment can be attributed to the rising geriatric and obese population and the availability of research funding are the major factors driving the market growth. Initiatives by key players are also expected to contribute to the market.

Breakdown of supply-side primary interviews, by company type, designation, and region:

By Company Type: Tier 1 (20%) , Tier 2 (45%), and Tier 3 (35%)

By Designation: C-level (30%), Director-level (20%), and Others (50%)

By Region: North America (33%), Europe (24%), AsiaPacific (27%), and Rest of the World (16%)

The some of the major players operating in this market are GlaxoSmithKline plc. (UK), Astellas Pharma Inc. (Japan), Merck & Co., Inc. (US), Eli Lilly and Company (US), and Teleflex Incorporated (US).

List of Companies Profiled in the Report

Boston Scientific Corporation (US)

Coloplast Group (Denmark)

Teleflex Incorporated (US)

Olympus Corporation (Japan)

GlaxoSmithKline PLC (UK)

Eli Lilly (US)

Pfizer, Inc. (US)

Abbott (US)

Asahi Kasei Corporation (Japan)

Merck & Co., Inc. (US)

Astellas Pharma Inc. (Japan)

Allergan plc (Ireland)

Alembic (India)

IPG Photonics Corporation (US)

Richard Wolf GmbH (Germany)

Unilab, Inc. (Philippines)

Pharex Health Corporation (Philippines)

Biolitec AG (Austria)

Urologix, LLC (US)

Advin Health Care (India)

Medifocus, Inc. (Canada)

Asclepion Laser Technologies GmbH (Germany)

Pnn Medical A/S (Denmark)

Surgical Lasers Inc. (Canada)

Quanta Systems (Italy)

Allium Ltd. (Israel)

Lumenis Ltd. (Israel)

KARL STORZ SE & Co. KG (Germany)

SRS Medical (US).

Research Coverage

This report studies the benign prostatic hyperplasia treatment market based on type, end user and region. The report also analyzes factors (such as drivers, restraints, challenges, and opportunities) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total benign prostatic hyperplasia treatment market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on benign prostatic hyperplasia treatment offered by the top 29 players in the benign prostatic hyperplasia treatment market. The report analyzes the benign prostatic hyperplasia treatment markettype, end user, and region.

Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devices across key geographic regions.

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the benign prostatic hyperplasia treatment market

Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the benign prostatic hyperplasia treatment market

Frequently asked questions

What are the growth opportunities in the benign prostatic hyperplasia treatment market across major regions in the future?

Which type of drug is expected to hold the largest share in the benign prostatic hyperplasia treatment market?

Which form of surgery has been widely used in BPH treatment?

Which region has a well-developed benign prostatic hyperplasia treatment market?

What is the impact of COVID-19 on benign prostatic hyperplasia treatment market?

#Medical Device

0 notes

industrystudyreport · 5 years ago

Text

Resectoscope Market Business Developments Opportunities and Forecast Research Report, 2018 - 2023

Global Resectoscopes Market is anticipated to grow significantly in the forecast period owing to the high prevalence of urogenital disorders. Resectoscope is a surgical instrument used for operating prostate, bladder, uterus, or urethra. The instrument is used for extracting tissue for bioscopy, prevents unwanted tissue growth using surgical methods or removes the damaged or diseased tissue. Resectoscope is integrated with a camera (an angle microscope) and an extraction device (a wire loop) that visualize the surgical site for surgeons for performing surgery.

The key drivers of resectoscope industry include rise in female elderly population, increase in adoption of minimally invasive medical procedures, increase in disposable income of consumers, improvements in healthcare infrastructure, rise in gynaecological disorders, and growing number of technological advancements in the domain. Some of the technological advancements in resectoscope instrument include integration of video-capabilities with roller ball, bipolar, roller barrel, and cutting loop electrodes, which has considerably increased the adoption of resectoscopes for medical surgeries. Rise in number of urogenital disorders, such as urinary incontinence, benign prostatic hyperplasia (BPH), hematuri, and urinary tract infection has accelerated to demand for resectoscopes.

However, growing technological advancements like microwave, lasers, Photo-selective laser vaporization of the Prostate (PVP), radio waves, and ultrasound in the substitutes for reducing the invasive aspect in urogenital disorders is hampering resectoscope segment. Nonetheless, growing and improving healthcare market in developing economies and free-trade agreements is an opportunity for the players operating in resectoscope market.

Get Free Sample Copy Of This Report @ https://www.millioninsights.com/industry-reports/resectoscopes-market/request-sample

Resectoscopes industry is categorized on the basis of electrode type, application, and geography. On the basis of electrode type, resectoscopes market is divided into bipolar, roller barrel, grooved roller, straight cutting loop, monopolar, and roller ball. Bipolar resectoscope segment is expected to hold significant share of the market owing to the security and effectiveness offered in hysteroscopic surgeries. In comparison to the monopolar resectoscope, bipolar resectoscope also offers advantages like low chances of risks by using saline solution, less bleeding while resection, better visibility, less alterations of tissue, low cost, and better cutting and coagulation by plasma of bipolar current.

In terms of application, resectoscope industry is split into Ambulance Surgery Centres (ASCs), Hospitals, Clinics, and others. Hospital segment leads the market due to improved healthcare infrastructure and better services for patients offered by the segment.

Geographically, resectoscope market is segmented as North America, South America, Europe, Asia Pacific, and Middle East & Africa. North America and Europe are predicted to dominate the market in the coming years owing to high prevalence of urogenital disorders like benign prostatic obstruction (BPO) and Benign prostatic hyperplasia (BPH). Furthermore, Asia Pacific is the second largest contributor to the market due to growing elderly population, rising focus on research and development activities, and increase in number of urinary tract infections.

The key players in resectoscopes industry include Karl Storz GmbH & Co. Kg, Cook Medical, Stryker Corporation, Olympus Corporation, Hologic, Boston Scientific Corporation, EndoChoice, Medtronic, Coopersurgical, Inc, and Ethicon.

Browse Related Category Reports @ https://industriesstudyreport.blogspot.com/

0 notes

marketresearchlove-blog · 5 years ago

Text

Asia-Pacific Benign Prostatic Hyperplasia Devices Market – Industry Trends and Forecast to 2026

Request-a-sample@https://www.databridgemarketresearch.com/request-a-sample/?dbmr=asia-pacific-benign-prostatic-hyperplasia-devices-market

Asia-Pacific Benign Prostatic Hyperplasia Devices Market By Procedure Type (Transurethral Resection of the Prostate (TURP), Prostatic Urethral Lift, Prostatectomy, Laser Surgery, Transurethral Microwave Therapy (TUMT), Transurethral Needle Ablation of the Prostate (TUNA), Prostatic Stenting/Implants, Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers), Country (China, Japan, India, Australia, South Korea, Singapore, Malaysia, Indonesia, Thailand, Philippines, Rest of Asia-Pacific) – Industry Trends and Forecast to 2026

Benign prostatic hyperplasia is also called as BPH which is a condition in men where the prostate gland is enlarged and is not cancerous. Benign prostatic hyperplasia is also known as benign prostatic obstruction or benign prostatic hypertrophy. The prostate usually goes through 2 main growth stages as a man ages. The first stage happens early in puberty, when prostate doubles in size, whereas the second phase of growth occurs around the age of 25 and continues through most of a man’s life. BPH often happens with the second stage of growth.

Asia-Pacific benign prostatic hyperplasia devices market is expected to reach at a CAGR of 12.2% in the forecast period of

Speak-to-analyst@https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=asia-pacific-benign-prostatic-hyperplasia-devices-market

Segmentation: Asia-Pacific Benign Prostatic Hyperplasia Devices Market

The Asia-Pacific benign prostatic hyperplasia devices market is segmented based on procedure type and end user.

· On the basis of procedure type, the market is segmented into transurethral resection of the prostate (TURP), prostatic urethral lift, prostatectomy, laser surgery, transurethral microwave therapy (TUMT), transurethral needle ablation of the prostate (TUNA), prostatic stenting/implants and others. Laser surgery is sub-segmented into holmium lasers, green light laser/PVP and thulium laser based devices. The others segment is sub-segmented into water-induced thermotherapy, high-intensity frequency ultrasound (HIFU), prostatic artery embolization (PAE) and others. Prostatic urethral lift segment is growing at the highest CAGR of 14.4% in the forecast period of 2019 to 2026.

o In October 2015, Lumenis launched pulse laser systems which can be used for the prostate and stones treatment. The Pulse 50H laser and Pulse 100H systems is designed for the treatment of benign prostatic hyperplasia (BPH) and stones. The additions of pulse products show a key development to current urological solutions. This addition will help in increasing the company’s product line.

· On the basis of end user, the market is segmented into hospitals and clinics and ambulatory surgical centers. Hospitals and clinics are growing at the highest CAGR of 13.0% in the forecast period of 2019 to 2026.

o In February 2019, Teleflex Incorporated’s subsidiary Neotract, Inc (U.S.) expanded its UroLift business. Humana which is a one of the nation’s largest private health insurers is now providing insurance coverage for the UroLift system. This will help the company in grasping more customers.

Request for Toc@ https://www.databridgemarketresearch.com/toc/?dbmr=asia-pacific-benign-prostatic-hyperplasia-devices-market

Competitive Analysis: Asia-Pacific Benign Prostatic Hyperplasia Devices Market

Some of the major players operating in this market are KARL STORZ SE & Co. KG, Olympus Corporation, Richard Wolf GmbH, Lumenis, Urologix, LLC, Boston Scientific Corporation, Coloplast Corp, LISA Laser Products GmbH, Medifocus, Inc., Coloplast Corp, Teleflex Incorporated, Urotech Devices, BD, PROCEPT BioRobotics Corporation, Biolitec AG and others.

Product Launch:

· In January 2019, Boston Scientific Corporation has launched Rezūm water vapor therapy and the randomized clinical trial results shows that it offers long-lasting results in minimally invasive treatment for benign prostatic hyperplasia (BPH). This product launch will increase the company’s product line.

· In March 2017, Biolitec has launched XCAVATOR laser fiber which can be used in the benign prostatic hyperplasia (BPH) treatment. The laser fiber can remove tissue on the prostate at a rate of 3 to 4 grams per minute. This new technological advanced product will offer the urologist an attractive option for their surgery and this will help to increase the company’s product line.

· In January 2016, Medifocus Inc. announced the engagement of the Tanaka Kapec Design Group, Inc. as a lead designer of the next generation Prolieve Thermodilatation System. This combinational therapy helped in offering both immediate and the long term relief in the BPH related symptoms.

· In October 2015, Lumenis launched pulse laser systems which can be used for the prostate and stones treatment. The Pulse 50H laser and Pulse 100H systems is designed for the treatment of benign prostatic hyperplasia (BPH) and stones. The additions of pulse products show a key development to current urological solutions. This addition will help to increase the company’s product line.

· In September 2014, Lisa Laser USA has launched RevoLix 200watt for the BPH treatment. It uses the wavelength of 2013 nm, which targets the water in the tissue, providing superior vaporization, cutting and hemostasis of the prostate. The company will be benefitted from the launch as the product launch will increase the company’s product portfolio.

· In 2011, Urologix signed an exclusive worldwide license for Prostiva RF Therapy System which is used for BPH treatment from Medtronic, Inc. This helped in expanding the product portfolio of the company.

Global Asia-Pacific Benign Market Size, Status and Forecast 2018 – 2025

· 1 Market Overview

· 2 Manufacturers Profiles

· 3 Global Sea Liner Compounds Sales, Revenue, Market Share and Competition by Manufacturer

· �� 4 Global Sea Liner Compounds Sales Market Analysis by Regions

· 5 North America Sea Liner Compounds Sales Diagnostics by Countries

· 6 Europe Sea Liner Compounds Sales by Countries

· 7 Asia-Pacific Sea Liner Compounds Sales by Countries

· 8 South America Sea Liner Compounds Sales by Countries

· 9 Middle East and Africa Sea Liner Compounds Sales by Countries

· 10 Sea Liner Compounds Sales Market Segment by Type

· 11 Sea Liner Compounds Sales Market Segment by Application

· 12 Sea Liner Compounds Sales Market Forecast

· 13 Sales Channel, Distributors, Traders and Dealers

· 14 Research Findings and Conclusion

· 15 Appendixes

Buynow@https://www.databridgemarketresearch.com/checkout/buy/enterprise/asia-pacific-benign-prostatic-hyperplasia-devices-market

Reasons to Purchase this Report

· The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period

· Regions/Countries that are expected to witness the fastest growth rates during the forecast period

· The latest developments, market shares, and strategies that are employed by the major market players

Research Methodology: Asia-Pacific Benign Prostatic Hyperplasia Devices Market

Primary Respondents:

Key Opinion Leaders (KOL’s): Manufacturer, Healthcare Professionals, Doctors, Nurses, Medical practitioners.

Industry Participants: CEO’s, V.P.’s, Marketing/Product Managers, Market Intelligence Managers and, National Sales Managers.

About Us:

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

0 notes

market-insider · 5 years ago

Text

Nephrology and Urology Devices Market Analysis Report And Segment Forecasts, 2018 - 2024

Industry Insights

The global nephrology and urology devices market size was estimated at USD 18.03 billion in 2016 and is expected to develop at a CAGR of 7.1% over the forecast period. Increasing prevalence of kidney failure and end-stage renal diseases has resulted in clinical urgency for devices that can improve existing patient outcomes and curb long-term costs associated with treatment of kidney diseases.

For More Details Please Visit @

https://www.grandviewresearch.com/industry-analysis/nephrology-urology-devices-market

In addition, widening geriatric population base, which is highly susceptibility to these diseases, is expected to spur demand in the coming years. According to a research published in Medscape, kidney failure is one of the major causes for high mortality rate in U.S. As mentioned in a research published in NCBI, end-stage renal disease is a major cost driver in most healthcare systems across developed economies. As a result, rising awareness pertaining to renal replacements in these economies is presumed to provide lucrative growth opportunities in the market.

The market is driven by technological advancements in these devices such as extracorporeal shockwave lithotripsy, percutaneous methods for stone disintegration and extraction, and inclusion of prosthetics in urology. These technologies have resulted in improved capacities in kidney and urinary stone management and cater to larger patient volumes due to reduced treatment duration and recovery time. These technologies also reduce the probability of recurrence of stone formation and are being increasingly incorporated in pediatric urology.

Type Insights

Dialysis equipment held the dominant revenue share in the nephrology and urology devices market as of 2015. This is a consequence of high clinical urgency to curb unprecedented growth in renal failure globally. In addition, factors such as large procedural volumes, wide range availability, and relatively higher patient awareness levels are expected to help the segment maintain its dominant position throughout the forecast period. Moreover, easy availability and presence of a wide-scale portfolio are facilitating greater penetration of dialysis equipment, thus resulting in a larger market share.

Benign prostatic hyperplasia (BPH) is anticipated to witness lucrative growth over the forecast period owing to potential benefits associated with nephrology and urology devices in treatment of BPH as well as consistent advancements in these devices. In addition, innovation in surgical procedures has resulted in a lower morbidity rate, thus widening the scope for this segment.

The segment is also fueled by the ability of personalized medicine to cater to individual needs. Technological advancements such as inclusion of bipolar resectors, laser vaporization, and robotic prostatectomy are also anticipated to fuel demand for these devices in the coming years.

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of latest industry trends in each of the sub-segments from 2013 to 2024. For the purpose of this study, Grand View Research has segmented the global nephrology and urology devices market report on the basis of type and region:

· Type Outlook (Revenue, USD Billion, 2013 - 2024)

o Dialysis

o Urinary Stone

§ Ureteral stents

§ Lithotripters

o Urinary Incontinence & Pelvic Organ Prolapsed

§ Sacral neuromodulation

§ Vaginal meshes & slings

§ Ureteral inserts & pessaries

o Benign Prostatic Hyperplasia

§ Catheter ablation

§ Prostatic stents

o Endoscopy

o Others

· Regional Outlook (Revenue, USD Billion, 2013 - 2024)

o North America

§ U.S.

§ Canada

o Europe

§ U.K.

§ Germany

o Asia Pacific

§ Japan

§ China

§ India

o Latin America

§ Brazil

§ Mexico

o Middle East & Africa

§ South Africa

#Nephrology and Urology Devices Market #healthcar

0 notes

medicaldevicetech · 6 years ago

Text

Global Urology Devices Market 2019 Assessment On Competition 2023

Market Synopsis: Market Research Future (MRFR)’s latest report reveals that the global urology devices market is poised to thrive at 7.1% CAGR during the forecast period 2017 to 2023. Urology devices are effective in the treatment of ailments related to organs such as adrenal glands, urinary bladder, ureters, urethra, etc. In addition, the rising prevalence of diseases associated with male reproductive organs and female urinary tract system is likely to expedite the growth of the urology devices market in the upcoming years.

Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/1120

Urology device finds application in the treatment of diseases such as prostate cancer, traumatic injury, kidney stones, and congenital abnormalities among others. The increasing patient pool of these diseases is projected to catapult the urology devices market on the trajectory of growth during the projection period.

Investments are prognosticated to flow towards research & development of these devices. This, in turn, is anticipated to augment the urology devices market in the forthcoming years. The market is forecasted to remain highly lucrative over 2023. Furthermore, an expansion of market presence for these devices is foreseen, which is predicted to catalyze the proliferation of the global urology devices market. Nevertheless, expensiveness of urology devices remains impediments to market growth. Market Segmentation: On the basis of type, the global Urology Devices Market has been segmented into dialysis equipment, urinary stone treatment devices, dialysis equipment, endoscopy devices, urinary incontinence & pelvic organ prolapsed devices, benign prostatic hyperplasia treatment devices, and others.

The dialysis equipment segment is further sub-segmented into hemodialysis, peritoneal dialysis, and others.

The urinary stone treatment devices segment has been sub-segmented into lithotripsy, ureteral stents, and others.

The urinary incontinence & pelvic organ prolapsed devices segment are sub-segmented into urethral inserts & pessaries, sacral neuromodulator, vaginal meshes & slings, and others.

The benign prostatic hyperplasia treatment devices segment has been further sub-segmented into catheter ablation, prostatic stents, and others.

On the basis of technology, the urology devices market has been segmented into robotic surgery, minimally invasive surgery, and others.

On the basis of application, the global urology devices market has been segmented into prostate cancer, urinary stones, benign prostatic hyperplasia, urinary incontinence, and others.

On the basis of end-users, the urology devices market is segmented into ambulatory services, hospitals, and others. Regional Insights: The Global Urology Devices Market, by region, has been segmented into Americas, Europe, Asia Pacific, and the Middle East & Africa. Americas presently account for the largest share of the global market. It is expected to exhibit significant growth over the assessment period owing to technological developments, increasing healthcare expenditure and rising prevalence of diseases such as kidney stones, traumatic injury, etc.

Europe has the second largest share of the global urology devices market and is expected to retain its market share towards the end of the forecast period. The growth can be ascribed to the rising geriatric population and accelerated investments in research & development.

Asia Pacific is an extremely lucrative market and has been prognosticated to strike the highest CAGR over the projection period. The strong economic growth of the region coupled with developments in the healthcare sector is projected to drive the growth of the regional market. Meanwhile, the Middle East & Africa is poised to witness limited growth due to limited availability of standard healthcare facilities in certain regions. Competitive Landscape: Some of the key players profiled in the report are Medtronic (US), Boston Scientific Corporation (US), Karl Storz GmbH & Co. KG (Germany), Olympus Corporation (Japan), C. R. Bard, Inc. (US), Fresenius Medical Care AG & Co. KGaA (Germany), Cook (US), Dornier MedTech (Germany), Nikkiso Co. Ltd (Japan), Stryker (US), and HealthTronics, Inc (US).

Industry News: In April 2018, Dornier MedTech, a medical device company, has started direct sales in the U.S. for its Surgical Holmium Lasers and Fibers.

In November 2018, NeoTract, a manufacturer of devices in the field of urology, has received Shonin approval for UroLift® System which is useful in the treatment of benign prostatic hyperplasia (BPH).

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Table Of Contents

1 Introduction

1.1 Definition

1.2 Scope Of The Study

1.2.1 Research Objective

1.2.2 Assumptions & Limitations

1.2.2.1 Assumptions

1.2.2.2 Limitations

1.3 Market Structure:

2 Research Methodology

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

3 Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Macroeconomic Indicators

4 Market Factor Analysis

4.1 Porters Five Forces Model

Access Report Details @ https://www.marketresearchfuture.com/reports/urology-devices-market-1120

Health Care Industry Reports

Global Pituitary cancer Market Research Report- Forecast To 2022

Global Prostate cancer Market Research Report- Forecast To 2027

Inhalation Anesthesia Market Research Report - Global Forecast till 2025

Contact:

Market Research Future

+1 646 845 9312

Email: [email protected]

#Urology Devices Market #Urology Devices Market demand #Urology Devices Market trends #global Urology Devices Market #Urology Devices Market size #Urology Devices Market share #Urology Devices Market analysis

0 notes

coolluminaryland-blog1 · 6 years ago

Text

Transurethral resection of the prostate (TURP) Market to Reap Excessive Revenues by 2023

Transurethral resection of the prostate (TURP) is a surgical procedure to remove excess part of the prostate gland which obstructs normal urine flow. The prostate gland is a vital part of the male reproductive system which secretes fluid that nourishes and protects sperms. This obstructive condition of prostate is also referred as benign prostatic hyperplasia (BPH). Initial signs and symptoms of BPH are often vague, variable, and nonspecific, making its diagnosis challenging. During TURP procedure, prostate gland is investigated through the cystoscope (surgical instrument) and a small surgical tool is inserted through the cystoscope to remove the enlarged prostate.

Read Report Overview: https://www.transparencymarketresearch.com/transurethral-resection-prostate-market.html

Sometimes, the fluid that is used to flush bladder during transurethral resection enters into bloodstream and causes severe problems such as hypothermia, bradychardia and hypoxia. This condition is known as TUR syndrome and is temporary in nature.

For more than 60 year, TURP has been the gold standard for treating lower urinary tract obstructions caused by benign prostatic hyperplasia (BPH) and benign prostatic obstruction (BPO). Current technological advancements such as continuous-flow instruments, bipolar TURP and video-TURP have substantially decreased the mortality and morbidity due to urino-genital infections. Globally increasing elderly population has been identified as one of the major factors contributing to the growing demand for transurethral resection procedures. As per the U.S National Library of Medicine, 60% of men over the age of sixty years and 80% of men over the age of 80 years have been diagnosed as BPH patients.

Download Brochure Copy of this Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2910

Visual, hands-on access to the prostate, immediate removal of excess tissue and ability to combine with other procedures are some of the advantages of TURP over other available treatment options for lower urinary tract infections. Some major minimally invasive treatment options for BPH include lasers, microwave, radio waves, photoselective laser vaporization of the prostate (PVP) and ultrasound. These treatment options are expected to serve the market for TURP as growth restraints during the forecast period from 2014 to 2019. Moreover, medications, another possible treatment option such as alpha 1-blockers, antibiotics, finasteride and dutasteride to decrease the size of the prostate are also restraining the current TURP market.

View TOC with Figures and Tables: https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=2910

Resectoscopes, catheters and resectoscopes electrodes (monopolar electrodes bipolar electrodes, grooved roller turp electrodes and straight cutting loop turp electrodes) are some major devices that are widely used during TURP procedures.Based on geography, the TURP market has been analyzed as North America, Asia-Pacific,Europe, and the Rest of the World (RoW). North America and Europe held the largest shares in terms of market revenue of the global TURP market in 2013. The primary reasons for North America and Europe holding the leading positions in the global TURP market are high prevalence of lower urinary tract diseases such as BPH and BPO, and well established healthcare infrastructure in both the regions. According to the American Urological Association, 15 million men in the United States are symptomatic to BPH and in the approximately 150,000 people have TURPs performed each year. However, Asia-Pacific is expected to witness highest growth rate during the forecast period from 2014 to 2020. A number of factors such as increasing prevalence of urinary tract infections, aging population, increasing focus on research and development would be fuelling the growth of TURP market in Asia-Pacific in coming years. According to the Department of Economic and Social Affairs, United Nations, 23 million individuals aged 80 years or over were living in China in 2013. The Department of Economic and Social Affairs further states that nearly 10 million and 9 million individuals aged 80 years or over were living in India and Japan, respectively in 2013.Some of the major players in TURP market include Olympus Corporation, Richard Wolf, Degania Silicone Ltd, Limbs & Things Ltd and KARL STORZ GmbH & Co. KG.

0 notes

pragya1-blog · 6 years ago

Text

Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Current Trends and Future Aspect Analysis 2017 - 2025

Benign prostatic hyperplasia (BPH), also known as benign prostatic hypertrophy, is nonmalignant enlargement of the prostate gland. The prostate gland surrounds the urethra, which excretes urine from the bladder outside the body. Enlargement of the prostate gland leads to blockage of the urethra, thus causing problems during urination. It involves stromal and glandular epithelial hyperplasia, which occurs in the periurethral transition zone surrounding the urethra. The symptoms of benign prostatic hyperplasia includes urinary hesitancy, straining in initiating urination, dribbling, decreased force of stream, feeling of incomplete bladder emptying, frequent urination, dysuria and nocturia. Benign prostatic hyperplasiais is distinguished by progressive development of lower urinary tract symptoms (LUTS) due to prolonged obstruction of urine. The prevalence of LUTS due to benign prostatic hyperplasia increases with increasing age. In around 80% of men, moderate to severe symptoms are observed between the age of 60 to 80 years. The treatment options for benign prostatic hyperplasia are therapeutic and surgical procedures.

Obtain Report Details @

https://www.transparencymarketresearch.com/benign-prostatic-hyperplasia-treatment-devices-market.html

Benign prostatic hyperplasia occurs in almost all men. It is not cancer, and about 50% of men aged over 75 years have some symptoms of benign prostatic hyperplasia. It is usually caused by abnormal hormonal balance, and changes in cell growth. Increasing aging population worldwide, increasing prevalence and incidence of benign prostatic hyperplasia is a major driving force for the benign prostatic hyperplasia treatment device market. Increase in awareness of prostate cancer and urological disorders, new and innovative device development, and high rate of adoption of minimally invasive devices for treatment is further driving the growth of the market. High unmet needs associated with benign prostatic hyperplasia have encouraged key players to invest in research and development activities to develop novel devices at low cost for treatment of benign prostatic hyperplasia which has further contributed to the market growth globally. Medication treatment of benign prostatic hyperplasia usually leads to invasive procedures and leads to side effects due to which key players are taking initiatives to invent new devices which offer less invasive treatment for enlarged prostate treatment.

Request Report Brochure @

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=26861

The global benign prostatic hyperplasia market can be segmented by procedure type and end users. By procedure type, the market is segmented into laser based procedure and other energy based procedure. Laser based procedures can be segmented further into holmium lasers, green light laser, and thulium laser based devices. Other energy based procedures are transurethral microwave thermotherapy, transurethral needle ablation, high-intensity focused ultrasound (HIFU), water-induced thermotherapy, prostatic artery embolization, and prostatic implants. Prostatic implants are further segmented into stents and prostatic urethral lift devices. By end users, the market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and others. Hospitals account for the dominant market share of the benign prostatic hyperplasia market due to high rate of hospitalization of patients suffering from urological disorder in hospitals and early adoption of new devices in hospitals.

Enquiry for Discount on this Report @

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=26861

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The companyâ€™s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMRâ€™s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Transparency Market Research State Tower, 90 State Street, Suite 700 Albany, NY 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: [email protected] Website: www.transparencymarketresearch.com

#Benign Prostatic Hyperplasia (BPH) Treatment Devices Market

0 notes

healtcare · 4 years ago

Text

Global Benign Prostatic Hyperplasia Treatment Market

Global Benign Prostatic Hyperplasia Treatment Market is expected to reach US$ XX Mn by 2026 from US$ XX Mn in 2019, at a CAGR of 5.2% during the forecast period.

Global Benign Prostatic Hyperplasia Treatment Market Overview:

Global Benign Prostatic Hyperplasia Treatment Market Dynamics:

Global Benign Prostatic Hyperplasia Treatment Market Segment Analysis:

Global Benign Prostatic Hyperplasia Treatment Market Regional Insights:

Global Benign Prostatic Hyperplasia Treatment Market Key Developments:

Global Benign Prostatic Hyperplasia Treatment Market Scope: Inquire before buyingS

Global Benign Prostatic Hyperplasia Treatment Market, by Region

• North America • Europe • South America • MEA • APAC

Global Benign Prostatic Hyperplasia Treatment Market Key Players

#Benign Prostatic Hyperplasia Treatment #Benign Prostatic Hyperplasia

0 notes

healthcare-research-report-blog · 7 years ago

Text

Transurethral resection of the prostate Market Value Projected to Expand by 2023

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=6856

According to the American Urological Association, 15 million men in the United States are symptomatic to BPH and in the approximately 150,000 people have TURPs performed each year. However, Asia-Pacific is expected to witness highest growth rate during the forecast period from 2014 to 2020. A number of factors such as increasing prevalence of urinary tract infections, aging population, increasing focus on research and development would be fuelling the growth of TURP market in Asia-Pacific in coming years. According to the Department of Economic and Social Affairs, United Nations, 23 million individuals aged 80 years or over were living in China in 2013. The Department of Economic and Social Affairs further states that nearly 10 million and 9 million individuals aged 80 years or over were living in India and Japan, respectively in 2013.

Some of the major players in TURP market include Olympus Corporation, Richard Wolf, Degania Silicone Ltd, Limbs & Things Ltd and KARL STORZ GmbH & Co. KG.

Enquiry for discount on this report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=6856

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: [email protected]

Website: http://www.transparencymarketresearch.com

0 notes